By the time you read this, Election Day in the U.S. will be over. Similar to previous elections, healthcare has remained one of 2020 voters’ top concerns. Although this year’s election was historic for many reasons, one of the main storylines throughout was the largest public health crisis of our time – the global COVID-19 pandemic. As the pandemic continues to cause worrisome health and economic consequences that will need to be addressed in the coming months and years, it also presents opportunities for accelerating innovations in healthcare delivery and pharmaceutical development.